| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/03/2004 | US20040106661 Broadspecturm 2-amino-benzoxazole sulfonamide hiv protease inhibitors |
| 06/03/2004 | US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione |
| 06/03/2004 | US20040106657 Indolyl derivatives |
| 06/03/2004 | US20040106656 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/03/2004 | US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 06/03/2004 | US20040106654 Inhibitors of copper-containing amine oxidases |
| 06/03/2004 | US20040106646 Visual function disorder improving agents |
| 06/03/2004 | US20040106645 Antagonists of melanin concentrating hormone receptor |
| 06/03/2004 | US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide |
| 06/03/2004 | US20040106640 Aryl ether substituted imidazoquinolines |
| 06/03/2004 | US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/03/2004 | US20040106628 CX3CR1 receptor antagonists useful in the treatment or prophylaxis of neurodegenerative disorders, demyelinating disease and pain |
| 06/03/2004 | US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors |
| 06/03/2004 | US20040106626 amidine containing compounds which inhibit serine proteases |
| 06/03/2004 | US20040106625 Therapeutic agents useful for treating pain |
| 06/03/2004 | US20040106622 Aryl-substituted alicylic compound and medical composition comprising the same |
| 06/03/2004 | US20040106619 For prevention and/or treatment for HIV infection or AIDS induced by the infection |
| 06/03/2004 | US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity |
| 06/03/2004 | US20040106610 Antagonize pharmacological actions of the endogenous neuropeptide tachykinins known as neurokinins |
| 06/03/2004 | US20040106609 Pyranoindazoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106595 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof |
| 06/03/2004 | US20040106586 Hormone replacement therapy method and its administration form |
| 06/03/2004 | US20040106582 carbo-or heterocycle-ethynyl-substituted pyridines or pyrimidines; e.g., 2-[2-(pyridine-3-yl)ethynyl]-6-methyl-pyridine |
| 06/03/2004 | US20040106576 Derivatives of venlafaxine and methods of preparing and using the same |
| 06/03/2004 | US20040106575 2-Alkylated-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
| 06/03/2004 | US20040106574 4-substituted with a imidazo[1,2a]pyrid-3-yl or pyrazolo[2,3a]pyrid-3-yl ring |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events |
| 06/03/2004 | US20040106559 for inhibiting proteases |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106557 Peptide ligands for prostate specific antigen |
| 06/03/2004 | US20040106554 polypeptide analogs of myelin basic protein for treatment of multiple sclerosis |
| 06/03/2004 | US20040106550 comprises chondromodulin-1 protein which grows articular chondrocytes by itself or under coexistence with fibroblast growth factor, and is capable of suppressing hyper degradation of cartilage matrix; gene therapy |
| 06/03/2004 | US20040106540 Method of treating cancer |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040105907 Anti-inflammatory effects of the partially purified extract of radix stephaniae tetrandrae |
| 06/03/2004 | US20040105900 Extracts derived from Pueraria mirifica, Butea superba and/or Mucuna collettii and extraction thereof |
| 06/03/2004 | US20040105863 Method to search for male antifertility drugs based on PHGPx activity determination |
| 06/03/2004 | US20040105862 Human TIMP-1 antibodies |
| 06/03/2004 | US20040105857 Methods and compositions for enhancing angiogenesis |
| 06/03/2004 | CA2506581A1 Novel 2',5'-oligoadenylic acid analogues |
| 06/03/2004 | CA2506245A1 Exon 1.beta. of pdgf receptor .alpha. gene and utilization thereof |
| 06/03/2004 | CA2506050A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424557A1 Use of g protein-coupled receptor protein |
| 06/02/2004 | EP1424393A2 Mammalian cytokine-like polypeptide-10 |
| 06/02/2004 | EP1424392A1 Novel secretory proteins and dna thereof |
| 06/02/2004 | EP1424336A1 1,3-benzothiazinone derivatives and use thereof |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424330A1 Activator for peroxisome proliferator-responsive receptor delta |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1424080A1 Gnrh agonist combination drugs |
| 06/02/2004 | EP1424067A1 Injectable foam and novel pharmaceutical applications thereof |
| 06/02/2004 | EP1424066A1 Dry compositions comprising hydrophobic stabilisers |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423436A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids |
| 06/02/2004 | EP1423430A1 A method of producing antibodies ex-vivo |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423413A1 Peptidic compounds selectively binding to p-selectin |
| 06/02/2004 | EP1423410A2 Peptides having a c-terminal hydroxylamino group as inhibitors of dipeptidyl peptidase i |
| 06/02/2004 | EP1423409A2 Gastrokines and derived peptides including inhibitors |
| 06/02/2004 | EP1423407A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423391A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423389A1 Pyrazolo-pyridines for the treatment of herpes infections |
| 06/02/2004 | EP1423388A2 2-arylamino-pyrimidines for the treatment of gsk3-related disorders |
| 06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 06/02/2004 | EP1423382A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423378A1 Aminopyrrole compounds as antiinflammatory agents |
| 06/02/2004 | EP1423376A1 Bicyclic compound, production and use thereof |
| 06/02/2004 | EP1423375A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof |
| 06/02/2004 | EP1423368A1 Urea and thiourea derivatives as non-nucleoside reverse transcriptase inhibitors |
| 06/02/2004 | EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors |
| 06/02/2004 | EP1423169A2 Potentiator composition comprising a terpene for enhancing the therapeutical effect of antitumoral agents in the treatment of cancer |
| 06/02/2004 | EP1423168A2 Pharmaceutical composition comprising gabapentin or an analogue thereof and an $g(a)-aminoamide and its analgesic use |
| 06/02/2004 | EP1423167A1 Method for treating alzheimer's disease using quinaldoyl-amine derivatives of oxo- and hydroxy-substituted hydrocarbons |
| 06/02/2004 | EP1423165A2 Intravaginal administration of an aromatase inhibitor for the treatment of oestrogen-dependent proliferative disorders |
| 06/02/2004 | EP1423150A2 Sustained release of microcrystalline peptide suspensions |
| 06/02/2004 | EP1423147A1 Prostaglandin compositions and methods of treatment for male erectile dysfunction |
| 06/02/2004 | EP1423146A1 Composition for treating parkinson's disease containing a cb1 receptor antagonist and a product activating dopaminergic neurotransmission in the brain |
| 06/02/2004 | EP1423145A1 Compositions for the treatment of parkinson's disease containing a cb1 receptor antagonist and a product that activates dopaminergic neurotransmission in the brain |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423131A1 Calcium salts with cytotoxic activity |
| 06/02/2004 | EP1423130A1 Antithrombotic compositions comprising low molecular weight heparin and low molecular weight dermatan sulphate |
| 06/02/2004 | EP1423128A2 Methods for the treatment of chronic pain anc compositions therefor |
| 06/02/2004 | EP1423127A1 Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors |
| 06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |
| 06/02/2004 | EP1423121A1 Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases |
| 06/02/2004 | EP1423120A1 2h-phthalazin-1-ones and methods for use thereof |
| 06/02/2004 | EP1423119A1 Heterobicycles fkbp-ligands |
| 06/02/2004 | EP1423117A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |